Literature DB >> 24938402

Impaired brain energy metabolism in the BACHD mouse model of Huntington's disease: critical role of astrocyte-neuron interactions.

Lydie Boussicault1, Anne-Sophie Hérard1, Noel Calingasan2, Fanny Petit1, Carole Malgorn1, Nicolas Merienne1, Caroline Jan1, Marie-Claude Gaillard1, Rodrigo Lerchundi3, Luis F Barros3, Carole Escartin1, Thierry Delzescaux1, Jean Mariani4, Philippe Hantraye1, M Flint Beal2, Emmanuel Brouillet1, Céline Véga4, Gilles Bonvento1.   

Abstract

Huntington's disease (HD) is caused by cytosine-adenine-guanine (CAG) repeat expansions in the huntingtin (Htt) gene. Although early energy metabolic alterations in HD are likely to contribute to later neurodegenerative processes, the cellular and molecular mechanisms responsible for these metabolic alterations are not well characterized. Using the BACHD mice that express the full-length mutant huntingtin (mHtt) protein with 97 glutamine repeats, we first demonstrated localized in vivo changes in brain glucose use reminiscent of what is observed in premanifest HD carriers. Using biochemical, molecular, and functional analyses on different primary cell culture models from BACHD mice, we observed that mHtt does not directly affect metabolic activity in a cell autonomous manner. However, coculture of neurons with astrocytes from wild-type or BACHD mice identified mutant astrocytes as a source of adverse non-cell autonomous effects on neuron energy metabolism possibly by increasing oxidative stress. These results suggest that astrocyte-to-neuron signaling is involved in early energy metabolic alterations in HD.

Entities:  

Mesh:

Year:  2014        PMID: 24938402      PMCID: PMC4158666          DOI: 10.1038/jcbfm.2014.110

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  41 in total

Review 1.  Energy deficit in Huntington disease: why it matters.

Authors:  Fanny Mochel; Ronald G Haller
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

2.  Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.

Authors:  Albertine Dubois; Anne-Sophie Hérard; Benoît Delatour; Philippe Hantraye; Gilles Bonvento; Marc Dhenain; Thierry Delzescaux
Journal:  Neuroimage       Date:  2010-03-04       Impact factor: 6.556

3.  Astrocyte-neuron lactate transport is required for long-term memory formation.

Authors:  Akinobu Suzuki; Sarah A Stern; Ozlem Bozdagi; George W Huntley; Ruth H Walker; Pierre J Magistretti; Cristina M Alberini
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

4.  Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice.

Authors:  Jennifer Bradford; Ji-Yeon Shin; Meredith Roberts; Chuan-En Wang; Guoqing Sheng; Shihua Li; Xiao-Jiang Li
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

5.  Mutant huntingtin causes metabolic imbalance by disruption of hypothalamic neurocircuits.

Authors:  Sofia Hult; Rana Soylu; Tomas Björklund; Bengt F Belgardt; Jan Mauer; Jens C Brüning; Deniz Kirik; Åsa Petersén
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

6.  Cholesterol defect is marked across multiple rodent models of Huntington's disease and is manifest in astrocytes.

Authors:  Marta Valenza; Valerio Leoni; Joanna M Karasinska; Lara Petricca; Jianjia Fan; Jeffrey Carroll; Mahmoud A Pouladi; Elisa Fossale; Huu Phuc Nguyen; Olaf Riess; Marcy MacDonald; Cheryl Wellington; Stefano DiDonato; Michael Hayden; Elena Cattaneo
Journal:  J Neurosci       Date:  2010-08-11       Impact factor: 6.167

7.  Nuclear factor erythroid 2-related factor 2 facilitates neuronal glutathione synthesis by upregulating neuronal excitatory amino acid transporter 3 expression.

Authors:  Carole Escartin; Seok Joon Won; Carole Malgorn; Gwennaelle Auregan; Ari E Berman; Pei-Chun Chen; Nicole Déglon; Jeffrey A Johnson; Sang Won Suh; Raymond A Swanson
Journal:  J Neurosci       Date:  2011-05-18       Impact factor: 6.167

Review 8.  Molecular mechanisms and potential therapeutical targets in Huntington's disease.

Authors:  Chiara Zuccato; Marta Valenza; Elena Cattaneo
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

9.  Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism.

Authors:  Ma Alba Sorolla; Ma José Rodríguez-Colman; Jordi Tamarit; Zaira Ortega; José J Lucas; Isidre Ferrer; Joaquim Ros; Elisa Cabiscol
Journal:  Free Radic Biol Med       Date:  2010-08-15       Impact factor: 7.376

10.  In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects.

Authors:  Mathilde Faideau; Jinho Kim; Kerry Cormier; Richard Gilmore; Mackenzie Welch; Gwennaelle Auregan; Noelle Dufour; Martine Guillermier; Emmanuel Brouillet; Philippe Hantraye; Nicole Déglon; Robert J Ferrante; Gilles Bonvento
Journal:  Hum Mol Genet       Date:  2010-05-21       Impact factor: 6.150

View more
  28 in total

1.  Metabolic Reprogramming in Astrocytes Distinguishes Region-Specific Neuronal Susceptibility in Huntington Mice.

Authors:  Aris A Polyzos; Do Yup Lee; Rupsa Datta; Meghan Hauser; Helen Budworth; Amy Holt; Stephanie Mihalik; Pike Goldschmidt; Ken Frankel; Kelly Trego; Michael J Bennett; Jerry Vockley; Ke Xu; Enrico Gratton; Cynthia T McMurray
Journal:  Cell Metab       Date:  2019-03-28       Impact factor: 27.287

Review 2.  The chicken or the egg: mitochondrial dysfunction as a cause or consequence of toxicity in Huntington's disease.

Authors:  Aris A Polyzos; Cynthia T McMurray
Journal:  Mech Ageing Dev       Date:  2016-09-12       Impact factor: 5.432

3.  Oxidative metabolism in YAC128 mouse model of Huntington's disease.

Authors:  James Hamilton; Jessica J Pellman; Tatiana Brustovetsky; Robert A Harris; Nickolay Brustovetsky
Journal:  Hum Mol Genet       Date:  2015-06-03       Impact factor: 6.150

Review 4.  Mutant Huntingtin and Elusive Defects in Oxidative Metabolism and Mitochondrial Calcium Handling.

Authors:  Nickolay Brustovetsky
Journal:  Mol Neurobiol       Date:  2015-05-05       Impact factor: 5.590

5.  αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease.

Authors:  Ana Osório Oliveira; Alexander Osmand; Tiago Fleming Outeiro; Paul Joseph Muchowski; Steven Finkbeiner
Journal:  Hum Mol Genet       Date:  2016-02-26       Impact factor: 6.150

Review 6.  Imaging and spectroscopic approaches to probe brain energy metabolism dysregulation in neurodegenerative diseases.

Authors:  Gilles Bonvento; Julien Valette; Julien Flament; Fanny Mochel; Emmanuel Brouillet
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-09       Impact factor: 6.200

7.  HACE1 is essential for astrocyte mitochondrial function and influences Huntington disease phenotypes in vivo.

Authors:  Dagmar E Ehrnhoefer; Amber L Southwell; Meenalochani Sivasubramanian; Xiaofan Qiu; Erika B Villanueva; Yuanyun Xie; Sabine Waltl; Lisa Anderson; Anita Fazeli; Lorenzo Casal; Boguslaw Felczak; Michelle Tsang; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2018-01-15       Impact factor: 6.150

8.  Mutant huntingtin does not cross the mitochondrial outer membrane.

Authors:  James Hamilton; Tatiana Brustovetsky; Rajesh Khanna; Nickolay Brustovetsky
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

9.  Beyond the redox imbalance: Oxidative stress contributes to an impaired GLUT3 modulation in Huntington's disease.

Authors:  Adriana Covarrubias-Pinto; Pablo Moll; Macarena Solís-Maldonado; Aníbal I Acuña; Andrea Riveros; María Paz Miró; Eduardo Papic; Felipe A Beltrán; Carlos Cepeda; Ilona I Concha; Sebastián Brauchi; Maite A Castro
Journal:  Free Radic Biol Med       Date:  2015-10-09       Impact factor: 7.376

10.  Enhanced mitochondrial biogenesis ameliorates disease phenotype in a full-length mouse model of Huntington's disease.

Authors:  Abhishek Chandra; Abhijeet Sharma; Noel Y Calingasan; Joshua M White; Yevgeniya Shurubor; X William Yang; M Flint Beal; Ashu Johri
Journal:  Hum Mol Genet       Date:  2016-03-22       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.